Bingley P J, Bonifacio E, Gale E A
Department of Diabetes and Metabolism, St. Bartholomew's Hospital, London, United Kingdom.
Diabetes. 1993 Feb;42(2):213-20. doi: 10.2337/diab.42.2.213.
Risk of progression to IDDM has been assessed extensively in first-degree relatives of IDDM patients, and highly specific prediction is possible within a small subset of this population. Because approximately 90% of future cases will come from those who have no close relative with IDDM, prediction and intervention within the general population will become the main priority for the future. This review presents a decision tree analysis of risk of progression to IDDM, highlights the different prognosis of markers when applied to those with and without a family history of the disease, and proposes a strategy for disease prediction in the latter. Large collaborative studies in well-characterized populations will allow new predictive markers and models to be evaluated, and strategies of intervention to be tested with maximum efficiency and minimal delay.
对1型糖尿病患者的一级亲属进展为1型糖尿病的风险已进行了广泛评估,并且在这一人群的一小部分中可以进行高度特异性的预测。由于未来约90%的病例将来自那些没有1型糖尿病近亲的人群,因此普通人群中的预测和干预将成为未来的主要重点。本综述对进展为1型糖尿病的风险进行了决策树分析,强调了这些标志物应用于有和没有该病家族史人群时的不同预后,并提出了针对后者的疾病预测策略。在特征明确的人群中开展大型合作研究,将能够评估新的预测标志物和模型,并以最高效率和最短延迟对干预策略进行测试。